Renaissance Technologies - ACUMEN PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$363
+68.8%
87,400
+95.1%
0.00%
Q2 2023$215
+41.4%
44,800
+19.6%
0.00%
Q1 2023$152
-12.6%
37,445
+15.9%
0.00%
Q4 2022$174
-99.9%
32,300
+49.5%
0.00%
Q4 2021$146,00021,6090.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$18,4525.05%
Knollwood Investment Advisory, LLC 1,678,510$9,063,9543.55%
GUARDIAN POINT CAPITAL, LP 300,000$1,620,0001.28%
GREAT POINT PARTNERS LLC 1,116,581$6,029,5371.18%
RA Capital Management 9,770,773$52,762,1741.07%
Deep Track Capital, LP 3,952,000$21,340,8000.90%
Cheyne Capital Management (UK) LLP 55,829$301,4770.53%
SILVERARC CAPITAL MANAGEMENT, LLC 295,115$1,593,6210.46%
COMMODORE CAPITAL LP 498,315$2,6910.41%
Ikarian Capital, LLC 254,945$1,376,7030.33%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders